These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11069386)

  • 21. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
    Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
    Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide.
    Tong da Y; Wen XQ; Jin Y; Liu ZW; Sun HY; Zhou FJ; Wu XY
    Asian Pac J Cancer Prev; 2010; 11(6):1805-9. PubMed ID: 21338237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue.
    Crescioli C; Villari D; Forti G; Ferruzzi P; Petrone L; Vannelli GB; Adorini L; Salerno R; Serio M; Maggi M
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):69-75. PubMed ID: 12573816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
    Hsieh JT; Chen SC; Yu HJ; Chang HC
    Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
    Gerdes MJ; Dang TD; Larsen M; Rowley DR
    Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10.
    Nakano K; Fukabori Y; Itoh N; Lu W; Kan M; McKeehan WL; Yamanaka H
    Endocr J; 1999 Jun; 46(3):405-13. PubMed ID: 10503993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
    Chatterjee B
    Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.
    Bonnet P; Reiter E; Bruyninx M; Sente B; Dombrowicz D; de Leval J; Closset J; Hennen G
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1203-8. PubMed ID: 7521342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft.
    Gregory CW; Kim D; Ye P; D'Ercole AJ; Pretlow TG; Mohler JL; French FS
    Endocrinology; 1999 May; 140(5):2372-81. PubMed ID: 10218991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.
    Guo N; Ye JJ; Liang SJ; Mineo R; Li SL; Giannini S; Plymate SR; Sikes RA; Fujita-Yamaguchi Y
    Growth Horm IGF Res; 2003 Feb; 13(1):44-53. PubMed ID: 12550081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion.
    Irwin JC; de las Fuentes L; Dsupin BA; Giudice LC
    Regul Pept; 1993 Oct; 48(1-2):165-77. PubMed ID: 7505463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
    Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.
    Gori F; Hofbauer LC; Conover CA; Khosla S
    Endocrinology; 1999 Dec; 140(12):5579-86. PubMed ID: 10579321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.